AKT1 and non-small cell lung carcinoma: In addition, Pectolinarigenin was able to inhibit NSCLC cell proliferation, promote apoptosis, and inhibit metastasis through the PTEN/PI3K/AKT signaling pathway, suggesting that Pectolinarigenin was a potential drug for NSCLC treatment (Xu et al., 2018).